ENZERNA
Enzerna Biosciences solution is to destroy the toxic RNA molecule that is the root cause of nucleotide expansion disorders using Artificial Site-Specific RNA Endonucleases (ASREs). ASREs are rationally designed proteins, that when expressed in cells, can target the expanded repeat array and destroy the disease-causing RNA.
ENZERNA
Industry:
Biotechnology Medical Therapeutics
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.enzerna.com
Total Employee:
1+
Status:
Active
Contact:
+ 1 919 307 6468
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Apache Wordpress Plugins
Current Employees Featured
Founder
Official Site Inspections
http://www.enzerna.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
- Host name: 8.50.212.35.bc.googleusercontent.com
- IP address: 35.212.50.8
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Enzerna"
Enzerna Biosciences Company Profile 2024: Valuation, Funding ...
Enzerna Biosciences’s primary industry is Biotechnology. Is Enzerna Biosciences a private or public company? Enzerna Biosciences is a Private company. What is Enzerna Biosciences’s …See details»
Enzerna Biosciences, LLC - VentureRadar
Enzerna Biosciences, Inc is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders. …See details»
Enzerna Biosciences, Inc Company Profile | Morrisville, NC ...
Find company research, competitor information, contact details & financial data for Enzerna Biosciences, Inc of Morrisville, NC. Get the latest business insights from Dun & Bradstreet.See details»
Enzerna Biosciences, Inc. - Drug pipelines, Patents, Clinical
Explore Enzerna Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Nervous System Diseases, Endocrinology ...See details»
Enzerna Biosciences - LinkedIn
Enzerna Biosciences, Inc is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders.See details»
Enzerna Biosciences - Overview, News & Similar companies
Enzerna Biosciences contact info: Phone number: (919) 307-6468 Website: www.enzerna.com What does Enzerna Biosciences do? Enzerna Biosciences, Inc is a pre-clinical stage company …See details»
Enzerna Biosciences Overview | SignalHire Company Profile
Organization Website: enzerna.com : Enzerna Biosciences industries Biotech: Headquarters Location: 125 South, chapel hill, ... 10-50 employees: Founded: 2013: Enzerna Biosciences …See details»
Enzerna - Company Profile - Tracxn
Nov 27, 2024 Enzerna is a molecular engineering reagent and custom-service company that has licensed proprietary technologies from UNC-Chapel Hill to create novel sequence-specific …See details»
Enzerna - Funding, Financials, Valuation & Investors - Crunchbase
Enzerna is funded by North Carolina Biotechnology Center. Unlock for free . Funding Rounds. Edit Funding Rounds Section. ... Show . How much funding has this organization raised over …See details»
Enzerna Biosciences Company Profile | Management and
Find contact information for Enzerna Biosciences. Learn about their Business Services market share, competitors, and Enzerna Biosciences's email format.See details»
Enzerna Biosciences LLC · 125 South Rd, Chapel Hill, NC 27514
ENZERNA BIOSCIENCES LLC is an entity in Chapel Hill, North Carolina registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The …See details»
Enzerna - Crunchbase
Enzerna Biosciences is a pre-clinical stage company. Start Free Trial . Chrome ExtensionSee details»
Enzerna Biosciences LLC Details - govtribe.com
Enzerna Biosciences LLC is a for-profit biotechnology company focused on developing protein-based therapeutics for genetic diseases. Through federal grants, the company conducts …See details»
ENZ-002 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 ENZ-002, Initially developed by Enzerna Biosciences, Inc., Now, its global highest R&D status is Pending, Therapeutic Areas: Nervous System Diseases,Congenital …See details»
Enzerna - Contacts, Employees, Board Members, Advisors & Alumni
Enzerna Biosciences is a pre-clinical stage company.See details»
Enzerna Biosciences | Durham NC - Facebook
Enzerna Biosciences, Research Triangle Park. 20 likes. Enzerna Biosciences, Inc is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term …See details»
Debt Financing - Enzerna - 2022-11-09 - Crunchbase
Nov 9, 2022 Organization Name . Enzerna . Announced Date Nov 9, 2022; Funding Type Debt Financing; Money Raised . $250K. Lead Investors. Edit Lead Investors Section. North Carolina …See details»
ENZ-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
ENZ-001: a DMPK gene modulators Drug, Initially developed by University of North Carolina System, Now, its global highest R&D status is Preclinical, Mechanism: DMPK gene …See details»
Enzerna - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Enzerna is actively using 5 technologies for its website, according to BuiltWith. These include Domain Not Resolving , U.S. Server Location , and CloudFront . Website Tech Stack by BuiltWithSee details»